US FTC wins key rulings against Amazon ahead of trial on Prime signups-March 2024-www.financetom.com

US FTC wins key rulings against Amazon ahead of trial on Prime signups

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FTC wins key rulings against Amazon ahead of trial on Prime signups

Sep 17, 2025 7:35 PM

WASHINGTON, Sept 17 (Reuters) - A judge ruled for the

U.S. Federal Trade Commission and against Amazon ( AMZN ) on

several key issues ahead of a trial next week on the agency's

claims that the retail giant's Prime subscription practices

violated consumer protection law.

(Reporting by Kanishka Singh in Washington and Jody Godoy in

New York; Editing by Muralikumar Anantharaman)

Previous page： Boeing CEO in battle to mend rifts after bitter strike ends Next page： --Federal Judge Grants Several of Google's Motions to Dismiss in Gift Card Class Action

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Boeing CEO in battle to mend rifts after bitter strike ends

Nov 6, 2024

SEATTLE (Reuters) -Ending the strike only stemmed the bleeding at Boeing ( BA ). Now, CEO Kelly Ortberg, just three months into the job, is faced with repairing a divided, demoralized, and drifting American corporate icon. More than 33,000 factory workers in the U.S. Northwest will trudge back to work over the next week after they voted by a slim...

--Federal Judge Grants Several of Google's Motions to Dismiss in Gift Card Class Action

Nov 6, 2024

11:09 AM EST, 11/05/2024 (MT Newswires) -- Price: 171.10, Change: +0.42, Percent Change: +0.25 ...

Merus Gets FDA Extension on Prescription Drug User Fee Act Goal Date for Zenocutuzumab to Feb. 4

Nov 6, 2024

11:08 AM EST, 11/05/2024 (MT Newswires) -- Merus (MRUS) said Tuesday the US Food and Drug Administration has extended the Prescription Drug User Fee Act objective deadline for experimental NRG1+ cancer treatment zenocutuzumab. The regulator moved the deadline to Feb. 4 to allow more time to review recent information Merus submitted, the company said. Price: 51.25, Change: +0.02, Percent Change:...

Payoneer's Third-Quarter Growth Exceeds Views Amid B2B Momentum; Lifts Full-Year Outlook

Nov 6, 2024

11:09 AM EST, 11/05/2024 (MT Newswires) -- Shares of Payoneer Global ( PAYO ) soared intraday Tuesday after the digital payments company reported stronger-than-expected third-quarter growth and raised its full-year outlook amid business-to-business momentum. Revenue climbed to $248.3 million for the three months ended Sept. 30 from $208 million the year earlier and surpassed the $225.5 million average analyst estimate...